FFP3 Respirators and Ears - Effects on Middle Ear Pressure and Hearing

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-23

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is Prospective Basic Science Study whose aims are as follows:

1. To determine the effect of Filtering Facepiece (FFP3M) respirators on eustachian tube function and hearing
2. To evaluate the extent to which FFP3M respirators attenuate speech in decibels

The outcome measures are as follows:

1. Changes in baseline pure tone audiometry and tympanometry post intervention.
2. SNOT-22 Questionnaires before and after use of respirator
3. ETDQ7 questionnaire
4. Measurement of speech attenuation in decibels.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Gas Supply, Demand and Middle Ear Gas Balance -- Fly/Dive Simulation

NCT01976429

Middle-ear Barotrauma

COMPLETED NA

Extended High-frequency Hearing and Speech Perception

NCT05435989

Low-pass Filtering Speech

RECRUITING NA

Evaluating Changes in Middle Ear Pressure Caused by CPAP

NCT02882022

Eustachian Tube Disorder

WITHDRAWN NA

Controlled Phonation and Vocal Rest Programs After Acute Vocal Exertion in Healthy Adults

NCT03762993

Healthy

COMPLETED NA

Evaluation of the High Frequency Digit Triplet Test in Cystic Fibrosis

NCT02252601

Cystic Fibrosis Sensorineural Hearing Loss

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The use of facemasks is one of the key strategies for reducing human to human transmission of SARS-CoV-2. There is a variety of facemasks worn in the clinical environment ranging from simple facemasks to devices such as filtering face piece 3M (FFP3M) respirators which are mandatory for some clinicians performing aerosol generating procedures (AGPs.)

It has been shown that wearing face protective equipment attenuates sound causing decay in speech intelligibility, especially transmission of middle-to-high voice frequencies.It has been shown that wearing surgical masks results in up to 23.3% loss of speech intelligibility in noisy environments with advanced face personal protective equipment such as FFP3M devices, accounting for up to 69.0% reduction of speech intelligibility. A reduction in speech intelligibility leads to reduced understanding which may result in miscommunication thereby compromising patient safety. To date, there have been two critical incidents in our department due to miscommunication attributed to wearing FFP3M respirators.

Anecdotally, clinicians have reported nasal congestion and subjective hearing loss during FFP3M respirator usage and after, especially when they are worn for a prolonged period of time. Clinicians working in theatre may be required to wear these devices for a number of hours when involved with AGPs.

The secondary consequences of wearing FFP3M respirators for prolonged periods of time, especially in a theatre setting require scientific exploration. This study aims to investigate the effect of FFP3M respirators on middle ear pressure and hearing, and the extent to which FFP3M respirators attenuate sound. Investigators believe that a reduction in speech intelligibility is not the only explanation for the perception of hearing loss when using FFP3M respirators. Investigators postulate that a transient dysfunction in the eustachian tube pressure regulating system also contributes to hearing loss.

To test this hypothesis, investigators will measure hearing and middle ear pressure using pure tone audiometry and tympanometry before and during FFP3M usage. Investigators will also use SNOT-22 and ETDQ7 questionnaires which are validated patient reported outcome measures for nasal symptoms and eustachian tube function. Investigators hope that this study provides some understanding of the physiological effects of FFP3M respirators on hearing and sinonasal symptoms and improves our understanding of their impact on clinical practice. There are no current studies looking into the effects of FFP3M respirators on eustachian tube function.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eustachian Tube Dysfunction Hearing Disorders Nasal Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Prospective open label basic science study.

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FFP3 Respirator

Participants will wear FFP3 respirators during the study.

Group Type EXPERIMENTAL

FFP3 Mask

Intervention Type OTHER

Participans will wear FFP3 respirators during the study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

FFP3 Mask

Participans will wear FFP3 respirators during the study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthcare workers that already have their own masks, fitted and provided by the Trust for day-to-day clinical use
* Participants without pre-existing sinonasal symptoms or previous sinonasal surgery
* Participants without pre-existing hearing loss or a history of otological procedures

Exclusion Criteria

* Participants with pre-existing sinonasal symptoms or previous sinonasal surgery
* Participants with pre-existing hearing loss or a history of otological procedures
* Participants who do not satisfy the requirements set out in the pre-registration questionnaire

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes